News Opinion Editor's Corner TCT 2017 My Takeaways From TCT 2017: Show Up, Keep It Civil, and Bring Your Best Self Shelley Wood November 22, 2017
Presentation TCT 2017 When and Which Antiplatelet Agent Should Be Dropped When Using Oral Anticoagulant Therapy? Presenter: Robert A. Harrington, Kurt Huber, Roxana Mehran November 01, 2017
News Conference News TCT 2017 Shortened DAPT Durations Appear Safe for Patients With ACS Implanted With DES Todd Neale November 01, 2017
Presentation TCT 2017 The Big Picture: Incremental Bleeding Risks in Patients Requiring Chronic Oral Anticoagulants Plus Antiplatelet Therapy Presenter: Robert A. Harrington, Kurt Huber, Renato D. Lopes November 01, 2017
News Conference News TCT 2017 DES With Bioresorbable Polymer Outperforms BMS in SENIOR Patients Michael O'Riordan November 01, 2017
Presentation TCT 2017 TCT 101: Safety of Double Antiplatelet Therapy as an Alternative to Warfarin Plus Aspirin After Left Atrial Appendage Device Closure - Short-Term Results of WATCHMAN-DAPT Multi-Center Registry Presenter: Brij Maini, Petr Neuzil, Grzegorz Smolka, MD October 31, 2017
News Conference News TCT 2017 Long-term Absorb BVS Data Continue to Disappoint Michael O'Riordan October 31, 2017
Presentation TCT 2017 TCT 76: Impact of Post-Discharge Dual Antiplatelet Therapy vs Aspirin Alone After CABG in Patients With Left Main Disease: Results from the EXCEL Trial Presenter: Adrian P. Banning, John D. Puskas, Christopher Kelly, MD October 31, 2017
News Conference News TCT 2017 No Advantage With Hybrid Revascularization for Multivessel Disease: HREVS Michael O'Riordan October 30, 2017
News Conference News TCT 2017 DARE Supports Drug-Coated Balloon as Alternative to DES for Any In-Stent Restenosis Todd Neale October 30, 2017
Presentation TCT 2017 Utility of Genotyping and Platelet Function Testing to Guide Antiplatelet Therapy: 2017 Assessment Presenter: Dominick J. Angiolillo, Marco Valgimigli, Thomas Engstroem October 30, 2017
News Conference News TCT 2017 Help for Clinicians Whose Patients Need to Switch P2Y12 Inhibitors Todd Neale October 30, 2017
Presentation TCT 2017 Predicting the Future: Will the Ongoing TWILIGHT and GLOBAL LEADERS Trials Change The Current Recommended Approach to Chronic Antiplatelet Therapy? Presenter: C. Michael Gibson, Stephan Windecker, Eric R. Bates October 30, 2017
News Conference News TCT 2017 TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More Shelley Wood October 20, 2017